Literature DB >> 26107718

Are Cancer Survivors Physically Active? A Comparison by US States.

Stacey L Tannenbaum1, Laura A McClure, Taghrid Asfar, Recinda L Sherman, William G LeBlanc, David J Lee.   

Abstract

BACKGROUND: Cancer survivors who engage in physical activity (PA) have improved quality of life, reduced fatigue, and lower mortality rates. We compare the percentage of cancer survivors meeting PA recommendations for US states, stratified by age and gender, to identify the need for PA education and intervention among cancer survivors.
METHODS: Pooled data from the 1997-2010 National Health Interview Survey were used to determine and rank age-adjusted PA by state. American Cancer Society guidelines (≥150 min/wk of PA) were used to compare prevalence by state, stratified by age group (< 65 and ≥65) and gender.
RESULTS: Thirty-three percent of cancer survivors met PA recommendations. The highest age-adjusted compliance to PA recommendations was in Vermont (59.9%, 95% confidence interval [CI], 40.8-76.3) and the lowest was in Louisiana (14.8%, 95% CI, 9.6-22.1) and Mississippi (15.5%, 95% CI, 10.4-22.3). The lowest percentages meeting recommendations were in Arkansas for males (8.6%, 95% CI, 7.0-10.6), Louisiana for females (12.5%, 95% CI, 6.8-21.9), Louisiana for survivors < 65 (15.6%, 95% CI, 10.5-22.6), and West Virginia for those ≥65 years (12.7%, 95% CI, 7.6-20.6).
CONCLUSIONS: Meeting PA recommendations by cancer survivors varies markedly by state of residence. Future efforts should target states with low percentages, tailoring interventions to the special needs of this high-risk population. The importance of PA should be incorporated within cancer survivorship care plans.

Entities:  

Mesh:

Year:  2015        PMID: 26107718     DOI: 10.1123/jpah.2014-0493

Source DB:  PubMed          Journal:  J Phys Act Health        ISSN: 1543-3080


  1 in total

1.  Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life.

Authors:  Neel S Iyer; Kathryn Osann; Susie Hsieh; Jo A Tucker; Bradley J Monk; Edward L Nelson; Lari Wenzel
Journal:  Clin Ther       Date:  2016-02-27       Impact factor: 3.393

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.